Skip to main content
Clinical Trials/NCT00792259
NCT00792259
Completed
Not Applicable

Topcon 3D OCT-1000 Optical Coherence Tomography System for Measurements of Retinal and RNFL Thicknesses: Precision and Agreement Study

Topcon Medical Systems, Inc.4 sites in 1 country48 target enrollmentOctober 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Retinal Disease
Sponsor
Topcon Medical Systems, Inc.
Enrollment
48
Locations
4
Primary Endpoint
Precision and Agreement Between the Topcon 3D OCT 1000 and the Identified Predicate Device
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this clinical protocol is to perform a comparison of Retinal and Retinal Nerve Fiber Layer (RNFL) thickness measurements between the Topcon 3D-1000 and the identified predicate device. In addition, this protocol performs a comparison of the thickness measurement results from images collected and analyzed with the Zeiss Stratus OCT to images collected with the Zeiss Stratus OCT and imported into the Topcon 3D OCT-1000 StratusViewer for analysis.

Registry
clinicaltrials.gov
Start Date
October 2008
End Date
November 2008
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female
  • Between 18 and 80 years of age
  • Either eye, but only one eye per subject will be enrolled
  • Topcon image quality factor ≥ 45 or Stratus signal strength ≥ 5.

Exclusion Criteria

  • Any known ocular disease
  • Any systemic disease that could result in ocular manifestations such as hypertension, diabetes, heart disease, etc.
  • Topcon image quality factor ≤ 44 or Stratus signal strength \<
  • Retinal Disease
  • Inclusion Criteria:
  • Male or female
  • Between 18 and 80 years of age
  • Either eye, but only one eye per subject will be enrolled
  • Symptoms consistent with one of the following retinal diseases: diabetic macular edema, cystoid macular edema, epiretinal membrane, macular hole, wet AMD and dry AMD for which OCT imaging is warranted. At lease one (1) case each of these diseases will be included in the study
  • A range of retinal thickness will be included

Outcomes

Primary Outcomes

Precision and Agreement Between the Topcon 3D OCT 1000 and the Identified Predicate Device

Time Frame: 30 Minutes

The precision and agreement measures the thickness of RNFL and Full Retinal Thickness of the study device and is compared to the predicate device to show agreement. Keywords, ILM - Internal Limiting Membrane RPE - Retinal Pigment Epithelium RNFL - Retinal Nerve Fiber Layer

Study Sites (4)

Loading locations...

Similar Trials